Ultrasound Acute Chest Syndrome Sickle Cell Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 25
SponsorIndiana University
About this trial
Feasibility and reliability of ultrasound in the inpatient hematology setting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 0-25 years old
Diagnosis: Patients with a documented diagnosis of sickle cell disease (any genotype)
Disposition: Hospitalized for a SCD-related complication (e.g. VOC)
Disqualifiers
Patient is considered hemodynamically unstable to undergo consent and study procedures
Already has diagnosis of ACS prior to admission to inpatient unit
POCUS operator not available
Trial design
Design model
Single group
Treatments tested in this trial
Point of Care Ultrasound
DevicePoint of Care Ultrasound during hospitalization
Treatment groups
30 Participants
are divided into 1 treatment groupGroup A: UltrasoundExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Participation rate
Percentage of patients who are approached for study who agree to be on study
Time frame
Up to 5 days2
Retention rate
Percentage of patients who remain on study
Time frame
Up to 5 days3
Duration of exam
Time taken to complete POCUS examination
Time frame
Up to 5 days4
Acceptability of POCUS by the medical team (physicians and nursing)
Acceptability measured using a 5-point Likert Scale (Strongly Agree to Strongly Disagree) regarding use of POCUS in inpatient setting.
Time frame
Up to 5 daysSecondary outcomes
1
Reliability of point of care ultrasound (POCUS) compared to standard of care (Chest X-ray)
A positive screening of acute chest syndrome by POCUS is identification of either a lung consolidation or focal B-lines. POCUS findings will be compared to standard of care (Chest X-ray) findings to see if findings concur.
Time frame
Up to 5 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov